Article
p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2.
Molecular and cellular biology - 15 Nov 2018
Cloer E W, Siesser P F, Cousins E M, Goldfarb D, Mowrey D D, Harrison J S, Weir S J, Dokholyan N V, Major M B
Abstract excerpt
Cancer-derived loss-of-function mutations in the KEAP1 tumor suppressor gene stabilize the NRF2 transcription factor, resulting in a prosurvival gene expression program that alters cellular metabolism and neutralizes oxidative stress. In a recent genotype-phenotype study, we classified 40% of KEAP1 mutations as ANCHOR mutants. By immunoprecipitation, these mutants bind more NRF2 than wild-type KEAP1 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
